Swaney, J S <br/><br/>
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.  [electronic resource] 

 -  British journal of pharmacology  Aug 2010 
 - 1699-713 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5381 
<br/><br/><label>Standard No.: </label>10.1111/j.1476-5381.2010.00828.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Bleomycin--pharmacology<br/>Bronchoalveolar Lavage Fluid--chemistry<br/>CHO Cells<br/>Calcium--metabolism<br/>Carbamates--administration & dosage<br/>Cell Line, Tumor<br/>Chemotaxis--drug effects<br/>Collagen--metabolism<br/>Cricetinae<br/>Cricetulus<br/>Disease Models, Animal<br/>Female<br/>Fibroblasts--cytology<br/>Humans<br/>Lung--drug effects<br/>Mice<br/>Mice, Inbred C57BL<br/>Phenylacetates--administration & dosage<br/>Pulmonary Fibrosis--drug therapy<br/>Rats<br/>Receptors, Lysophosphatidic Acid--antagonists & inhibitors<br/>Transfection